您要查找的是不是：
- Methods A total of 110 caes with advanced NSCLC were enrolled in study. 方法110例晚期NSCLC患者。
- IVP and MVP are effective and safe chemotherapeutic protocols for the treatment of advanced NSCLC patients. 以长春地辛为主的IVP及MVP方案为治疗晚期非小细胞肺癌较为有效而安全的化疗方
- Compared with MVP regimen,MNP regimen is a more effective and safer chemotherapy regimen for advanced NSCLC patients. MNP方案为治疗晚期NSCLC较为有效和安全的化疗方案
- Methods:To review the benefit: risk profile of Gefitinib and Erlotinib in Asian patients with advanced NSCLC. 目的回顾性分析亚裔晚期NSCLC患者使用吉非替尼的临床研究,了解亚裔患者使用吉非替尼后的疗效与毒性反应。
- Conclusions IFO combined with NVB have a higher efficacy and lower adverse effects on advanced NSCLC. 结论IFO与NVB是治疗晚期非小细胞肺癌疗效高，毒性较低的治疗方案。
- Methods 27 cases of advanced NSCLC patients received chemotherapy with NVB and PDD. 方法27例非小细胞肺癌(NSCLC)病人采用PDD+NVB方案化疗至少3周期。
- Palliative surgery should be a part of multidisciplinary therapy for selective patients with advanced NSCLC. 在经过选择的晚期非小细胞肺癌患者,减状性手术应为综合治疗的一部分。
- Conclusion IVP and MVP are effective and safe chemotherapeutic protocols for the treatment of advanced NSCLC patients. 结论以长春地辛为主的IVP及MVP方案为治疗晚期非小细胞肺癌较为有效而安全的化疗方案。
- Objective: To observe preliminary result of radiofrequency ablation and survival quality in advanced NSCLC. 目的:观察射频消融术治疗非小细胞肺癌的近期疗效及患者的生存质量。
- Methods:Sixty-two patients with advanced NSCLC were treated with combinative chemotherapy of MMC,VDS and DDP. 方法：62例晚期非小细胞肺癌患者接受MMC、VDS、DDP联合化疗，每3周重复疗程。
- OBJECTIVE:To compare of and evaluate the efficacy and adverse reaction of NP, MVP and ICE regimens in the treatment of patients with advanced NSCLC. 目的:比较NP方案和MVP方案及ICE方案治疗晚期非小细胞肺癌(NSCLC)的近期疗效和不良反应,指导临床选择治疗方案。
- The 3D-CRT concurrently combined with chemotherapy for locally advanced NSCLC could be more effective with higher side effects than the 3D-CRT only. 结论3D-CRT同步化疗治疗局部晚期NSCLC疗效较好,毒副反应患者能耐受,安全可行。
- Methods From February 2000 to June 2005, 79 patients with advanced NSCLC were treated with GP (GEMZAR 1000 mg/m2 d1,8; DDP 30 mg/m2 d1~3). 方法2000年2月至2005年6月,对79例NSCLC患者采用CP方案化疗,用法: GEM 1000 mg/m2第1、8天给药;
- Methods: From Jul 2004 to Apr 2006, 36 patients with locally advanced NSCLC were treated with 3DCRT combined with weekly docetaxel chemotherapy. 方法36例局部晚期NSCLC患者,实施3DCRT,照射剂量60Gy~72Gy。
- Both NP and IAP are effective and tolerable regimens for advanced NSCLC patients,but it seems that NP is better for retreated patients. 两方案对晚期NSCLC均有较好的疗效,可以耐受,但对于复发病例,选择NP方案似乎更为合适。
- Conclusion:The use of TP chemotherapy combined with thermotherapy can increase effect in the treatment of advanced NSCLC. 结论：TP方案局部热疗联合可提高单纯化疗治疗中晚期非小细胞肺癌的疗效。
- Objective To compare the effect,toxicity and quality of life between medroxyprogesterone acetate(MPA) plus MVP regimen and MPV regimen alone in patients with advanced NSCLC. 目的 观察患者服用甲孕酮合并 MVP方案与单纯使用 MVP方案化疗治疗初治非小细胞肺癌(non- small cell cancer,NSCL C)的疗效 ,生活质量改善 ,毒性等情况并加以比较。
- The response rate of MVP regimen is slightly higher than HVP regimen. MVP regimen should be selected firstly between the regimens in the chemotherapy of advanced NSCLC. MVP方案疗效稍高于HVP方案 ,所以化疗时宜选MVP方案
- Methods The clinical data of 78 case with advanced NSCLC treated with videsine plus cisplatin(VP,36 cases)and vinorebine plus cisplatin(NP,42 cases)were ananlysed. 方法 :对应用VP方案、NP方案治疗的 78例NSCLC的病例的临床资料进行统计分析。
- Methods Fifty-nine advanced NSCLC patients were divited into group A(TP chemotherapy alone) and group B (TP chemotherapy plus autologous CIK biotherapy). 方法59例患者分成A组（单用TP方案化疗）与B组（自体CIK联合TP方案治疗）。
